Since the early 2010s, scientists have increasingly turned to new approach methodologies (NAMs), a broad term for technologies designed to make research more accurate and ethical. Instead of relying mainly on animals, NAMs aim to replace or supplement them with tools that better reflect human biology.

One of the most talked-about examples is organoid technology. Organoids are tiny, three-dimensional clusters of human cells grown from stem cells that mimic real organs. Think “mini-organs in a dish.” Governments in the U.S. and U.K. have started integrating NAMs into policy, and organoids have entered mainstream conversations about reducing animal use in research.

The media plays a big role in shaping public understanding of these technologies. But the discussion isn’t just about science — it’s about ethics too. And how ethics is framed matters.

Most media attention focuses on human-centered ethics. Could brain organoids become conscious? Is it wrong to blur human-animal boundaries? What happens when human cells are transplanted into animals? Largely missing, however, is attention to animal welfare: how many animals are used, how they’re treated, and the severity of procedures.

This study looked at how U.S. and U.K. newspapers covered organoids from 2013 to 2024. Using an international media database, researchers identified 168 articles that mentioned organoids in the context of animal research. They applied the “Animal Research Nexus” framework to consider how science, ethics, regulation, and public opinion intersect, and tracked recurring patterns over time.

Right off the bat, it was clear that animals were rarely mentioned. Only about 35% of articles referred to them, and often only in passing as a comparison (“better than mice”) or in the context of chimeric experiments, where human organoids are transplanted into animals for testing. Discussion of animal suffering was scarce.

Media framing shifted in three phases over the decade:

1. Early optimism (2013 to 2016): Organoids were poised as exciting breakthroughs, promising both scientific progress and reduced animal use — a win-win. Ethical debates focused mainly on the moral status of human cells, especially in brain research.
2. Human-animal integration (2017 to 2022): As the science advanced, ethical questions around chimeric experiments intensified, mostly focusing on whether animals were becoming “too human.” Concerns about animal suffering or the use of animals remained secondary.
3. Ethical innovation and reform (2018 to 2024): After regulatory changes like the U.S. FDA Modernization Act 2.0, which allowed non-animal alternatives in drug development, organoids were increasingly portrayed as part of a shift away from animal testing. Animal models were described as outdated or poorly predictive, while organoids were labeled as “human-relevant” and broadly supported by society — unlike past biotech controversies like genetically modified foods. Support for organoid-based research from animal rights groups also featured prominently.

Yet the promise of replacement often outpaced the evidence. Many organoid experiments still rely on animals, especially in chimeric studies. In practice, animal research remains embedded in the system. Organoids may be reshaping the narrative around animal research more than actually reducing it. They signal ethical progress, even when animals are still being used.

The potential is real, but ethical innovation only counts if it leads to measurable outcomes. For advocates, this moment offers concrete opportunities to push for:

• Transparent reporting of when and how animals are used in organoid research
• Time-bound reduction targets linked to validated NAMs
• Dedicated funding and regulatory support for fully non-animal organoid pipelines

In short, organoids are widely portrayed as ethical replacements, but the reality is more complex. Animals continue to play a central role, often in ways media coverage doesn’t fully acknowledge. Whether organoids actually reduce animal use, or simply reframe the debate, will depend on whether institutions turn promise into practice.